Insight

New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer – MD Anderson Cancer Center

Photo taken from Heiko Enderling/Twitter

Apr 9, 2024, 13:09

New allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer – MD Anderson Cancer Center

MD Anderson Cancer Center shared on LinkedIn:

”At the 2024 American Association for Cancer Research Annual Meeting, our Samer Srour and Michael Migden presented results from two clinical trials highlighting novel immunotherapy advances, including a new allogeneic CAR T cell therapy for advanced kidney cancer and an oncolytic immunotherapy for organ transplant patients with skin cancer.
Learn about the findings.”

Source: MD Anderson Cancer Center/LinkedIn

2024 American Association for Cancer Research Annual Meeting AACR AACR24 cancer CAR T-cell therapy Cell Therapy clinical trials immunotherapy kidney cancer MD Anderson Cancer Center Michael Migden OncoDaily Oncology Samer Srour skin cancer

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage